Perrigo Company plc

(PRGO) Trade

By |

Profile

Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Contact Information

Website: www.perrigo.com
Email: Investor.Request@perrigo.com
Main Phone: +353 17094000
Address: The Sharp Building
Address 2: Hogan Place
City / Town: Dublin
Country: IRL
Postal Code: 2

Issuer Information

Exchange: NYE
CEO: Murray S. Kessler
Employees: 10600
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More


Gathering Data... Please wait

Profile

Perrigo is the leading provider of over-the-counter generic drugs with over 100 global locations. The company was formed in 1887 as a packager of home remedies and has grown with the migration of prescriptions switching to over the counter and later with strategic acquisitions. The company has a portfolio of more than 3,000 product formulations and 14,000 stock-keeping units. Most of its manufacturing and customer base reside in North America. With the most recent management change, the company announced a narrower focus on consumer wellness in conjunction with the divestiture of animal health, acquisition of Ranir Global Holdings, and plans to sell or spin off the prescription business.

Contact Information

Website: www.perrigo.com
Email: Investor.Request@perrigo.com
Main Phone: +353 17094000
Address: The Sharp Building
Address 2: Hogan Place
City / Town: Dublin
Country: IRL
Postal Code: 2

Issuer Information

Exchange: NYE
CEO: Murray S. Kessler
Employees: 10600
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 53.44 $ 1.44 (2.77%)
Last Price 53.44 Change $ 1.44 Change % 2.77 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 53.00 High 53.87 Low 52.79 Prev Close 52.00
Last Trade Volume 1 mi 52 Wk Hi 75.42 52 Wk Low 36.28
Market Cap 7.3 bi Ex-Div Date Div Rate 0.84 Yield 1.5720
Shares 136,054,652.00 EPS (TTM) 0.64 PE Ratio 84.60 Exchange NYSE
  Last 3 Mo Last 12 Mo
Number of Insider Trades 37 124
Number of Buys 28 66
Number of Sells 9 58
Net Activity 424603 445376
Last 10 Buys Shares
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Jeffrey C. Smith 1,000
Last 10 Sell Shares
Todd W. Kingma 1,000
John Wesolowski 1,000
John Wesolowski 1,000
John Wesolowski 1,000
John Wesolowski 1,000
Thomas M. Farrington 1,000
Ronald Craig Janish 1,000
Ronald Craig Janish 1,000
Jeffrey R. Needham 1,000
Jeffrey R. Needham 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 107 107 107 107
Low Target Price Estimate 81 77 77 81
Mean Target Price Estimate 91.92 90.86 90.13 91.92
Standard Deviation 7.53 8.26 8.44 7.53
Date of Most Recent Estimate 05/16/18 05/16/18 05/16/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 10 9 9 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.25 2.2 2.2 2.2